515 related articles for article (PubMed ID: 9339933)
1. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.
Turner RR; Ollila DW; Krasne DL; Giuliano AE
Ann Surg; 1997 Sep; 226(3):271-6; discussion 276-8. PubMed ID: 9339933
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
[TBL] [Abstract][Full Text] [Related]
3. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
Chu KU; Turner RR; Hansen NM; Brennan MB; Bilchik A; Giuliano AE
Ann Surg; 1999 Apr; 229(4):536-41. PubMed ID: 10203087
[TBL] [Abstract][Full Text] [Related]
4. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
[TBL] [Abstract][Full Text] [Related]
5. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymphadenectomy in breast cancer.
Giuliano AE; Jones RC; Brennan M; Statman R
J Clin Oncol; 1997 Jun; 15(6):2345-50. PubMed ID: 9196149
[TBL] [Abstract][Full Text] [Related]
7. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis.
Chu KU; Turner RR; Hansen NM; Brennan MB; Giuliano AE
Ann Surg Oncol; 1999 Dec; 6(8):756-61. PubMed ID: 10622503
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
Pargaonkar AS; Beissner RS; Snyder S; Speights VO
Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer.
Choi YJ; Yun HR; Yoo KE; Kim JH; Nam SJ; Choi YL; Ko YH; Kim BT; Yang JH
Jpn J Clin Oncol; 2006 Aug; 36(8):489-93. PubMed ID: 16790449
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymphadenectomy for breast cancer in a community managed care setting.
Guenther JM; Krishnamoorthy M; Tan LR
Cancer J Sci Am; 1997; 3(6):336-40. PubMed ID: 9403045
[TBL] [Abstract][Full Text] [Related]
15. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes.
Jakub JW; Diaz NM; Ebert MD; Cantor A; Reintgen DS; Dupont EL; Shons AR; Cox CE
Am J Surg; 2002 Oct; 184(4):302-6. PubMed ID: 12383888
[TBL] [Abstract][Full Text] [Related]
16. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden.
Stitzenberg KB; Meyer AA; Stern SL; Cance WG; Calvo BF; Klauber-DeMore N; Kim HJ; Sansbury L; Ollila DW
Ann Surg; 2003 May; 237(5):607-12; discussion 612-3. PubMed ID: 12724626
[TBL] [Abstract][Full Text] [Related]
17. Improved detection of metastases by step sectioning and immuno-histochemical staining of axillary sentinel nodes in patients with breast carcinoma.
Ensani F; Enayati L; Rajabiani A; Omranipour R; Alavi N; Mosahebi S
Asian Pac J Cancer Prev; 2013; 14(10):5731-4. PubMed ID: 24289570
[TBL] [Abstract][Full Text] [Related]
18. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases.
Menes TS; Tartter PI; Mizrachi H; Constantino J; Estabrook A; Smith SR
J Am Coll Surg; 2005 Mar; 200(3):323-7. PubMed ID: 15737841
[TBL] [Abstract][Full Text] [Related]
20. Anatomopathological analysis of sentinel and nonsentinel lymph nodes in breast cancer: hematoxylin-eosin versus immunohistochemistry.
Soares CT; Frederigue-Junior U; Luca LA
Int J Surg Pathol; 2007 Oct; 15(4):358-68. PubMed ID: 17913942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
